Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06558357
What this trial is testing

Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia Rheumatica

Who this might be right for
Inflammatory Rheumatism18-FDGPositron-emission Tomography
University Hospital, Brest 210
Testing effectiveness (Phase 2)WithdrawnNCT04757090
What this trial is testing

89Zr-Trastuzumab PET/CT in Subjects With Previously Treated HER2-Positive Solid Tumors Scheduled to Receive Treatment With MT-5111

Who this might be right for
HER2-positive Solid TumorHER-2 Positive Cancer
Washington University School of Medicine
Not applicableUnknownNCT05361135
What this trial is testing

18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia

Who this might be right for
Staphylococcus Aureus BacteremiaStaphylococcus Aureus SepticemiaSepsis Bacterial+4 more
University College, London 820
Not applicableUnknownNCT03768479
What this trial is testing

The Value of 18F-FES-PET/CT in Predicting Fulvestrant Efficacy in Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerFulvestrant
First Affiliated Hospital Xi'an Jiaotong University 68
Not applicableLooking for participantsNCT07331532
What this trial is testing

68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors

Who this might be right for
Breast Neoplasms、Lung Neoplasms、Pancreatic Neoplasms
Peking University First Hospital 10
Testing effectiveness (Phase 2)Study completedNCT02028364
What this trial is testing

Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women

Who this might be right for
Breast Cancer
Jules Bordet Institute 55
Very early researchLooking for participantsNCT06387381
What this trial is testing

68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive Disease

Who this might be right for
PSMAFAPPositron-Emission Tomography
First Affiliated Hospital of Chongqing Medical University 30
Early research (Phase 1)Ended earlyNCT03746704
What this trial is testing

Study of ImmunoPet Imaging of PD-L1 in Tumors Using 89Zr-DFO-REGN3504 in Adult Participants With Advanced PD-L1 Positive Malignancies

Who this might be right for
Advanced PD-L1 Positive Malignancies
Regeneron Pharmaceuticals 2
Not applicableEnded earlyNCT00358098
What this trial is testing

Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
AHS Cancer Control Alberta 51
Large-scale testing (Phase 3)UnknownNCT05861830
What this trial is testing

Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)

Who this might be right for
Advanced Breast Cancer
Peking Union Medical College Hospital 80
Large-scale testing (Phase 3)Ended earlyNCT06125028
What this trial is testing

[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma

Who this might be right for
Marginal Zone Lymphoma
Pentixapharm AG 8
Testing effectiveness (Phase 2)UnknownNCT03527628
What this trial is testing

OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy

Who this might be right for
Classical Hodgkin LymphomaHodgkin Lymphoma (Category)Hodgkin Disease+1 more
King Abdullah International Medical Research Center 220
Very early researchLooking for participantsNCT05659797
What this trial is testing

FES BPET-DBT in Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 20
Large-scale testing (Phase 3)Study completedNCT00784537
What this trial is testing

High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients

Who this might be right for
Hodgkin's Lymphoma
Fondazione Italiana Linfomi - ETS 520
Not applicableStudy completedNCT03726931
What this trial is testing

FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET

Who this might be right for
Breast Cancer
Amsterdam UMC, location VUmc 40
Testing effectiveness (Phase 2)Ended earlyNCT05563272
What this trial is testing

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Who this might be right for
Cervical CancerColorectal CancerEsophageal Cancer+16 more
Telix Pharmaceuticals (Innovations) Pty Ltd 11
Not applicableStudy completedNCT03507088
What this trial is testing

Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Zhimin Shao 36
Not applicableStudy completedNCT03718260
What this trial is testing

PSMA-PET Registry for Recurrent Prostate Cancer

Who this might be right for
Recurrent Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 9,684
Testing effectiveness (Phase 2)WithdrawnNCT04910425
What this trial is testing

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

Who this might be right for
Prostate Carcinoma
Northwestern University
Testing effectiveness (Phase 2)Active Not RecruitingNCT06457425
What this trial is testing

A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis

Who this might be right for
MF,PMF,PPV-MF,PET-MF
Chengdu Zenitar Biomedical Technology Co., Ltd 75
Next Page